Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation.

Expert Opinion on Biological Therapy
Ann M LeenC M Rooney

Abstract

Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for many hematological malignancies and genetic disorders. The majority of patients do not have a human leukocyte antigen (HLA) identical sibling donor, and alternative stem cell sources include HLA-matched or mismatched unrelated donors and haploidentical related donors. However, alternative donor HSCT are associated with three major complications i) graft rejection; ii) graft-versus-host disease (GvHD); and iii) delayed immune reconstitution leading to viral infections and relapse. Graft rejection and the risk of GvHD can be significantly reduced by using intensive conditioning regimens, including in vivo T cell depletion as well as ex vivo T cell depletion of the graft. However, the benefits of removing alloreactive T cells from the graft are offset by the concomitant removal of T cells with anti-viral or anti-tumor activity as well as the profound delay in endogenous T cell recovery post-transplant. Thus, opportunistic infections, many of which are not amenable to conventional small-molecule therapeutics, are frequent in these patients and are associated with significant morbidity and high mortality rates. This review discusses current cell therapies ...Continue Reading

References

Jun 1, 1992·The Journal of Infectious Diseases·R D HarringtonJ D Meyers
Feb 20, 1990·Journal of Immunological Methods·R A KnazekS A Rosenberg
Sep 8, 1994·The New England Journal of Medicine·H E HeslopC M Rooney
Apr 1, 1994·The Journal of Infectious Diseases·P FlomenbergN Bunin
Oct 1, 1993·The American Journal of Medicine·R D Wong, M B Goetz
Jan 13, 1994·The New England Journal of Medicine·D L PorterJ H Antin
May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E WhimbeyG P Bodey
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R H CollinsJ Nemunaitis
Oct 14, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P D ColeN A Kernan
Mar 20, 1999·Bone Marrow Transplantation·G A HaleC C Patrick
Jun 3, 1999·The New England Journal of Medicine·E C GuinanJ G Gribben
Aug 28, 1999·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·D L PorterJ H Antin
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D S HowardC Pomeroy
Feb 7, 2001·Journal of Computer Assisted Tomography·J P KoT C McLoud
Oct 18, 2000·The Journal of Experimental Medicine·R M KedlP Marrack
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J ElizagaK Ward
Mar 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A M La RosaE Whimbey
Mar 30, 2001·Bone Marrow Transplantation·U HohenthalP Kotilainen
Oct 13, 2001·The Journal of Infectious Diseases·K J CortezJ E Bennett
Nov 10, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A VilchezS Kusne
Dec 4, 2001·Nature Immunology·Ross M KedlPhilippa Marrack
Nov 8, 2002·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A YangoA Wahbeh

❮ Previous
Next ❯

Citations

Aug 2, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·John A Barrett
Jan 1, 2014·Molecular Therapy. Methods & Clinical Development·Pradip BajgainJuan F Vera
Mar 26, 2014·Expert Opinion on Biological Therapy·Assaf Marcus, Zelig Eshhar
Apr 9, 2014·Early Human Development·Marco ZeccaPatrizia Comoli
Nov 30, 2013·Advances in Hematology·Winnie Wy Ip, Waseem Qasim
Feb 28, 2016·The Journal of Allergy and Clinical Immunology·Swati NaikMichael D Keller
Jan 25, 2017·Current Allergy and Asthma Reports·Lauren P McLaughlinMichael Keller
Jun 4, 2019·International Journal of Molecular Sciences·Sung-Yeon ChoHee-Je Kim
Sep 3, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C AspordJ Plumas
Feb 8, 2019·Journal of Hematology & Oncology·Theresa KaeuferleTobias Feuchtinger
Jun 26, 2020·Frontiers in Medicine·Sanjana Fatema Chowdhury, Saeed Anwar
Jun 14, 2019·Leukemia·Noga Or-GevaYair Reisner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.